BIOMAT Database Logo BIOMAT Database Logo

Induction of immunomodulator transcriptional responses by cholera toxin. 2006

Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Department of Chemistry, Georgetown University, 654 Reiss Science Bldg, Washington, DC 20057, USA.

Cholera toxin (CT) is the causative agent of cholera, binds to GM1 glycosphingolipids, induces the production of cellular cAMP and is also a very powerful mucosal adjuvant. Although the mechanism of the CT induction of cAMP production is well understood, molecular mechanisms of the adjuvanticity of cholera toxin are yet to be delineated. Here, we examined the interaction of CT with human lymphocytes and monocytes by analyzing the host transcriptional profiles using cDNA arrays. The time courses of the transcriptional activations and repressions of affected genes in lymphocytes and monocytes in response to cholera toxin were determined. CT induced the expression of IL-8 and MIP-1 early in the CT exposure. VEGF, TIMP1, HIF-1alpha, MMP11, hek 8, MCP1, IL-6, GCP 2, urokinase plasminogen activator, and TNF-alpha receptor were upregulated after 4h CT treatment. These genes showed increased expression for 48 h. MRP-14, MRP-8A increased expression after 16 h CT treatment. RT-PCR and real-time PCR using cDNA specific primers confirmed the CT induction and repression of selected genes. The results suggest that immunomodulatory genes were among the genes that were affected the most by CT, and induction of these genes may contribute to the CT adjuvanticity.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002772 Cholera Toxin An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells. Cholera Toxin A,Cholera Toxin B,Cholera Toxin Protomer A,Cholera Toxin Protomer B,Cholera Toxin Subunit A,Cholera Toxin Subunit B,Choleragen,Choleragenoid,Cholera Enterotoxin CT,Cholera Exotoxin,Cholera Toxin A Subunit,Cholera Toxin B Subunit,Procholeragenoid,Enterotoxin CT, Cholera,Exotoxin, Cholera,Toxin A, Cholera,Toxin B, Cholera,Toxin, Cholera
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D020869 Gene Expression Profiling The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell. Gene Expression Analysis,Gene Expression Pattern Analysis,Transcript Expression Analysis,Transcriptome Profiling,Transcriptomics,mRNA Differential Display,Gene Expression Monitoring,Transcriptome Analysis,Analyses, Gene Expression,Analyses, Transcript Expression,Analyses, Transcriptome,Analysis, Gene Expression,Analysis, Transcript Expression,Analysis, Transcriptome,Differential Display, mRNA,Differential Displays, mRNA,Expression Analyses, Gene,Expression Analysis, Gene,Gene Expression Analyses,Gene Expression Monitorings,Gene Expression Profilings,Monitoring, Gene Expression,Monitorings, Gene Expression,Profiling, Gene Expression,Profiling, Transcriptome,Profilings, Gene Expression,Profilings, Transcriptome,Transcript Expression Analyses,Transcriptome Analyses,Transcriptome Profilings,mRNA Differential Displays

Related Publications

Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Induction of systemic immune responses in sheep by topical application of cholera toxin to skin.
December 2000, Veterinary immunology and immunopathology,
Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Induction of cytotoxic T lymphocyte responses by cholera toxin-treated bone marrow-derived dendritic cells.
April 2003, Vaccine,
Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Induction of polyclonal and monoclonal antibody responses to cholera toxin by the synthetic peptide approach.
March 1988, Molecular immunology,
Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Cholera toxin B subunit as an immunomodulator for mucosal vaccine delivery.
January 1999, Advances in veterinary medicine,
Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Modulation of in vivo antibody responses by cholera toxin.
January 1975, Journal of immunology (Baltimore, Md. : 1950),
Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Induction of tolerance in macrophages by cholera toxin B chain.
January 1999, Pathobiology : journal of immunopathology, molecular and cellular biology,
Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Oral administration of a bacterial immunomodulator enhances the immune response to cholera toxin.
August 1996, Vaccine,
Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Induction of cholera toxin receptors in cultured cells by butyric acid.
June 1979, The Journal of biological chemistry,
Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Induction of anchorage-independent growth of mouse JB6 cells by cholera toxin.
March 1987, Carcinogenesis,
Atabak R Royaee, and Rasha Hammamieh, and Chanaka Mendis, and Rina Das, and Marti Jett, and David C H Yang
Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR.
June 1984, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!